Atea Pharmaceuticals, Inc.

NasdaqGS:AVIR Stock Report

Mkt Cap: US$379.0m

Atea Pharmaceuticals Management

How experienced are the management team and are they aligned to shareholders interests?

2.4yrs

Average management tenure


CEO

Jean-Pierre Sommadossi (66 yo)

10.5yrs

Tenure

US$34,104,892

Compensation

Dr. Jean-Pierre Sommadossi, Ph D., is a Founder of Atea Pharmaceuticals, Inc. and has been its Chairman, Director, Chief Executive Officer and President since July 2012 and had been its Treasurer. Dr. Somm...


CEO Compensation Analysis

How has Jean-Pierre Sommadossi's remuneration changed compared to Atea Pharmaceuticals's earnings?
DateTotal Comp.SalaryCompany Earnings
Sep 30 2022n/an/a

US$36m

Jun 30 2022n/an/a

US$16m

Mar 31 2022n/an/a

US$48m

Dec 31 2021US$34mUS$650k

US$121m

Sep 30 2021n/an/a

US$25m

Jun 30 2021n/an/a

US$35m

Mar 31 2021n/an/a

US$24m

Dec 31 2020US$3mUS$437k

-US$11m

Sep 30 2020n/an/a

-US$36m

Jun 30 2020n/an/a

-US$22m

Mar 31 2020n/an/a

-US$16m

Dec 31 2019US$811kUS$400k

-US$14m

Compensation vs Market: Jean-Pierre's total compensation ($USD34.10M) is above average for companies of similar size in the US market ($USD2.50M).

Compensation vs Earnings: Jean-Pierre's compensation has increased by more than 20% in the past year.


Leadership Team

NamePositionTenureCompensationOwnership
Jean-Pierre Sommadossi
Founder10.5yrsUS$34.10m7.11%
$ 27.0m
Andrea Corcoran
CFO, Executive VP of Legal & Secretary9.08yrsUS$8.36m0.76%
$ 2.9m
John Vavricka
Chief Commercial Officer4.25yrsUS$6.60m0.099%
$ 375.4k
Janet M. J. Hammond
Chief Development Officer2.42yrsUS$9.01m0%
$ 0
Maria Horga
Chief Medical Officer2.42yrsUS$8.14m0%
$ 0
Wayne Foster
Executive VP of Finance & Chief Accounting Officerno datano datano data
Jonae Barnes
Senior Vice President of Investor Relations & Corporate Communications2yrsno datano data
Ariyapadi Krishnaraj
Vice President of Marketing1yrno datano data
Adel Moussa
Executive Vice President of Chemistryno datano datano data
Xiao-Jian Zhou
Executive Vice President of Early Stage Developmentno datano datano data
Keith Pietropaolo
Senior Vice President of Clinical Sciences3yrsno datano data
Jayanthi Wolf
Executive Vice President of Regulatory Affairs2yrsno datano data

2.4yrs

Average Tenure

59yo

Average Age

Experienced Management: AVIR's management team is considered experienced (2.4 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Jean-Pierre Sommadossi
Founder10.5yrsUS$34.10m7.11%
$ 27.0m
Barbara Duncan
Independent Director2.25yrsUS$602.11k0%
$ 0
Bruno Lucidi
Independent Director8.33yrsUS$592.04k0.060%
$ 227.5k
Franklin Berger
Lead Independent Director3.33yrsUS$622.67k0.93%
$ 3.5m
Bruce Polsky
Independent Director8.17yrsUS$593.91k0.060%
$ 227.5k
Polly Murphy
Independent Director2.42yrsUS$595.21k0.028%
$ 106.0k
Jerome Adams
Independent Director1.67yrsUS$971.45k0%
$ 0

3.3yrs

Average Tenure

62yo

Average Age

Experienced Board: AVIR's board of directors are considered experienced (3.3 years average tenure).